Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.

Carolina Barbosa Hannah FraserThomas J HoergerAlyssa LeibJennifer R HavensApril M YoungAlex KralKimberly PageJennifer EvansJon ZibbellSusan HaririClaudia VellozziLina NerlanderJohn W WardPeter Vickerman

Published in: Addiction (Abingdon, England) (2019)

Hepatitis C screening and treatment for people who inject drugs, combined with medication-assisted treatment and syringe-service programs, is a cost-effective strategy for reducing hepatitis C burden in the United States.

Keyphrases

healthcare
public health
hepatitis c virus
combination therapy
human immunodeficiency virus
replacement therapy
electronic health record
adverse drug